Does ELTROMBOPAG Cause Agranulocytosis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Agranulocytosis have been filed in association with ELTROMBOPAG. This represents 0.1% of all adverse event reports for ELTROMBOPAG.
5
Reports of Agranulocytosis with ELTROMBOPAG
0.1%
of all ELTROMBOPAG reports
1
Deaths
1
Hospitalizations
How Dangerous Is Agranulocytosis From ELTROMBOPAG?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Product use in unapproved indication (303)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which ELTROMBOPAG Alternatives Have Lower Agranulocytosis Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG